ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641383 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641383; 2) Community: the network communities that were significantly associated with the response to NSC 641383; 3) Molecule: the relationships between components within communities and NSC 641383; 4) MDR: the compounds that were significantly associated with the NSC 641383.

NSC Compound Enrichment Correlation
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.030556149892922 -0.074034919
NSC 684969 Null 0.0305561498929221 -0.010867508
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.0339770934764509 0.45619772
NSC 659996 Null 0.0339770934764509 0.37598075
NSC 665076 1,3-butadiene, 1,1,2,4,4-pentachloro-3-nitro- 0.0339770934764509 0.56410373
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0339770934764509 0.27437574
NSC 668300 Null 0.0339770934764509 0.23761202
NSC 710904 Null 0.0339770934764509 0.45738243
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.0339770934764509 0.63294429
NSC 681644 Camptothecin Derivative 0.0339770934764511 0.21780219
Total:57  Current:33    [First] [Prev] [Next] [Last]